NUS
NU Skin Enterprises Inc
$
9.120
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
10.745
Open
10.400
VWAP
9.25
Vol
1.26M
Mkt Cap
447.79M
Low
8.895
Amount
11.71M
EV/EBITDA(TTM)
--
Total Shares
49.67M
EV
423.84M
EV/OCF(TTM)
4.74
P/S(TTM)
0.29
Nu Skin Enterprises Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its brands include Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging. Its skin and beauty solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lifting and firming, lines and wrinkles, and oily skin and pores. Its nutrition solutions include bone and joint health, brain and memory, energy and stamina, heart health, immunity support, nail skin and hair health, and women's health. It offers various beauty devices, including ageLOC Rose Gold LumiSpa iO, ageLOC LumiSpa Silicone Head, ageLOC LumiSpa iO Stand and LumiSpa Rose Gold Accent Twin Pack.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q2
392.10M
-12%
0.300
+76.47%
374.20M
-13.01%
0.240
+14.29%
Estimates Revision
The market is revising No Change the revenue expectations for Nu Skin Enterprises, Inc. (NUS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 2.13%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+2.13%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for NU Skin Enterprises Inc (NUS.N) is 6.76, compared to its 5-year average forward P/E of 12.41. For a more detailed relative valuation and DCF analysis to assess NU Skin Enterprises Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
12.41
Current PE
6.76
Overvalued PE
16.88
Undervalued PE
7.94
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
6.35
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
9.02
Undervalued EV/EBITDA
3.69
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.75
Current PS
9.12
Overvalued PS
1.70
Undervalued PS
-0.21
Financials
Annual
Quarterly
FY2025Q3
YoY :
-15.33%
364.21M
Total Revenue
FY2025Q3
YoY :
+18.71%
21.64M
Operating Profit
FY2025Q3
YoY :
+105.72%
17.08M
Net Income after Tax
FY2025Q3
YoY :
+100.00%
0.34
EPS - Diluted
FY2025Q3
YoY :
-23.08%
17.57M
Free Cash Flow
FY2025Q3
YoY :
+0.59%
70.49
Gross Profit Margin - %
FY2025Q3
YoY :
-33.07%
3.42
FCF Margin - %
FY2025Q3
YoY :
+143.01%
4.69
Net Margin - %
FY2025Q3
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
318.7K
USD
2
3-6
Months
469.2K
USD
4
6-9
Months
0.0
USD
0
0-12
Months
13.1K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
49.0K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
127.0K
Volume
1
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
318.7K
USD
2
3-6
Months
469.2K
USD
4
6-9
Months
0.0
USD
0
0-12
Months
13.1K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
49.0K
USD
Months
0-12
0
0.0
USD
Months
NUS News & Events
Events Timeline
2025-11-06 (ET)
2025-11-06
16:28:39
Nu Skin projects FY25 EPS between $3.15 and $3.25
2025-11-06
16:28:12
Nu Skin Projects Q4 EPS Between 25c and 35c
2025-11-06
16:27:43
Nu Skin Announces Q3 EPS of 34 Cents, Up from 17 Cents Last Year
Sign Up For More Events
Sign Up For More Events
News
2.0
09-23NASDAQ.COMNu Skin (NUS) Shows Promise: Will Its 6.2% Surge Lead to Further Gains?
8.0
09-22NASDAQ.COMSignificant Options Activity on Monday: BBY, NUS, RUN
4.0
08-12NASDAQ.COMValidea Benjamin Graham Strategy Daily Upgrade Report - 8/12/2025
Sign Up For More News
People Also Watch
KRRO
Korro Bio Inc
33.840
USD
+3.90%
BARK
Bark Inc
0.790
USD
-0.38%
FRBA
FIRST BANK (Hamilton)
15.760
USD
-0.19%
EB
Eventbrite Inc
2.630
USD
+19.55%
NEWT
NewtekOne Inc
10.270
USD
+0.88%
TBRG
TruBridge Inc
19.420
USD
+0.94%
RR
Richtech Robotics Inc
3.740
USD
+0.54%
IHRT
iHeartMedia Inc
4.630
USD
-1.49%
LOCO
El Pollo Loco Holdings Inc
10.450
USD
+0.97%
GLUE
Monte Rosa Therapeutics Inc
12.310
USD
-5.38%
FAQ
What is NU Skin Enterprises Inc (NUS) stock price today?
The current price of NUS is 9.12 USD — it has decreased -15.79 % in the last trading day.
What is NU Skin Enterprises Inc (NUS)'s business?
What is the price predicton of NUS Stock?
What is NU Skin Enterprises Inc (NUS)'s revenue for the last quarter?
What is NU Skin Enterprises Inc (NUS)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for NU Skin Enterprises Inc (NUS)'s fundamentals?
How many employees does NU Skin Enterprises Inc (NUS). have?